Results 201 to 210 of about 144,142 (399)

Drug rash with eosinophilia and systemic symptoms (DRESS): A report of two cases

open access: diamond, 2022
M. C. R. Rama   +4 more
openalex   +1 more source

Guideline for the investigation and management of eosinophilia

open access: yesBritish Journal of Haematology, 2017
N. Butt   +12 more
semanticscholar   +1 more source

Ocular Microbiome in Dupilumab‐Induced Ocular Surface Disease

open access: yes
Allergy, EarlyView.
Andrea Leonardi   +4 more
wiley   +1 more source

Angiolymphoid Hyperplasia with Eosinophilia Involving the Occipital Artery: Case Report and Review of Literature

open access: gold, 2017
Laia Fite-Trepat   +4 more
openalex   +1 more source

Visceral Eosinophilia [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1955
openaire   +2 more sources

Standard complete blood count to predict long‐term outcomes in febrile infection–related epilepsy syndrome (FIRES): A multicenter study

open access: yesEpilepsia, EarlyView.
Abstract Objective We investigated whether complete blood count (CBC) analyses during intensive care unit stay could predict 12‐month outcomes in patients with cryptogenic febrile infection–related epilepsy syndrome (FIRES), a subset of new‐onset refractory status epilepticus (NORSE).
Martin Guillemaud   +36 more
wiley   +1 more source

A randomized, double‐blind, placebo‐controlled, multicenter study to evaluate the efficacy and safety of adjunctive cenobamate in Asian patients with focal seizures

open access: yesEpilepsia, EarlyView.
A randomized, double‐blind, placebo‐controlled, multicenter study to evaluate the efficacy and safety of adjunctive cenobamate in Asian patients with focal seizures. Abstract Objectives This randomized, double‐blind, placebo‐controlled study (NCT04557085), conducted in China, Japan, and the Republic of Korea, evaluated the efficacy and safety of ...
Sang Kun Lee   +20 more
wiley   +1 more source

Diffuse pruritic eruption and eosinophilia

open access: gold
Serena X. Zhang   +2 more
openalex   +1 more source

Home - About - Disclaimer - Privacy